Guide to Clinical Preventive Services: Report of the U. S. Preventive Services Task Force
An exhaustive report on recommended clinical preventive services that should be provided to patients in the course of routine clinical care, including screening for vascular, neoplastic and infectious diseases, and metabolic, hematologic, ophthalmologic and ontologic, prenatal, and musculoskeletal disorders. Also, mental disorders and substance abuse, counseling, and immunization. The majority of deaths below age 65 are preventable. This Guide results from the most comprehensive evaluation and synthesis of preventive interventions to date.
What people are saying - Write a review
We haven't found any reviews in the usual places.
abuse Academy of Family adolescents adults alcohol American Academy American College amniocentesis Ann Intern associated asymptomatic bacteriuria behavior benefit blood pressure Canadian Task Force Centers for Disease cervical cancer Chapter cholesterol Clin Clinical Intervention clinicians College of Obstetricians colorectal cancer contraception Control and Prevention coronary heart disease counseling diabetes diagnosis dietary Disease Control drug early detection efficacy elderly Epidemiol evaluation evidence to recommend fetal follow-up Group guidelines hepatitis high-risk hypertension immunization incidence increased risk infants injuries insufficient evidence IntJ JAMA Lancet maternal MMWR mortality neonatal neural tube defects obesity Obstet Gynecol Obstetricians and Gynecologists oral outcomes ovarian cancer patients Pediatrics Periodic Health Examination population pregnancy pregnant women prenatal prevalence primary programs prostate cancer Public Health randomized controlled trial rates reduce reported risk factors routine screening rubella scoliosis screening tests sensitivity serum sexual sigmoidoscopy syndrome therapy thyroid tion treatment ultrasound vaccine virus
Page 642 - Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol, in Adults (Adult Treatment Panel III).
Page 14 - A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
Page 34 - Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Page 539 - Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198 17.
Page 61 - Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.
Page 242 - Assessment of the iron nutritional status of the US population based on data collected in the Second National Health and Nutrition Examination Survey, 1976-1980.
Page 47 - Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.
Page 30 - National Cholesterol Education Program, Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II), NEH Pub.